A/Prof Jeremy Grummet discusses the upcoming prostate-specific antigen (PSA) guidelines and benefits, and increasing the quality of patient care with current management options available.
A/Prof Jeremy Grummet answers your most pressing questions regarding prostate cancer screening. These were compiled by GPs and health professionals around Australia.
You might think that more testosterone means greater vitality and wellbeing, but it’s more complicated than that says Professor Bu Yeap, consultant endocrinologist at Fiona Stanley Hospital, WA.
Urological surgeon and focal therapy pioneer explains how this treatment may be used for intermediate-risk localised prostate cancer – and potential risks and pitfalls. Standard curative treatments of localised prostate cancer – radical prostatectomy or radiotherapy – treat the whole prostate gland...
In this Product Explainer Endocrinologist A/Prof Kenneth Ho explains the role of testosterone scrotal cream for male hypogonadism confirmed by clinical assessment and measurement of serum testosterone (5 mins).
Urologists and prostate cancer advocates say our prostate-specific antigen testing guidelines are out-of-date, and don’t account for advances that have reduced harms. The NHMRC and RACGP Red Book guidelines are undergoing review, and may ultimately promote more widespread use of PSA testing. But globally, epidemiologists remain concerned about overdiagnosis and overtreatment…
This activity will focus on dementia prevention in primary care and will involve sending a link to a standardised questionnaire (CogDrisk) aimed at calculating a risk profile and identifying modifiable risk factors for dementia to all your patients between age 45-65, discussing the results with your patients and reporting on the outcomes in the report template provided.
In this Product Explainer, Urological Surgeon A/Prof Homi Zargar explains the role of Silodosin in the relief of lower urinary tract symptoms associated with benign prostatic hyperplasia or BPH (5 mins).
A high index of suspicion helps when looking out for androgen deficiency in younger males. Half of all patients with Klinefelter Syndrome remain undiagnosed